Looks like ARCH Venture Partners is gearing up for its ninth fund, with aims to raise $400 million, according to a regulatory filing. The Chicago-based early stage venture firm has a deep history in tech and life sciences investments – with some notable recent plays like Illumina offshoot Grail, Harvard 3D printing spinout Voxel 8, and Doug Williams’ brainchild Codiak Biosciences.
{iframe}http://medcitynews.com/2016/03/arch-venture-partners/?utm_source=MedCity+News+Subscribers&utm_campaign=80ae43ce5c-MCN+Daily+Email&utm_medium=email&utm_term=0_5092836c41-80ae43ce5c-408826397{/iframe}